Lamotrigina Viatris

Lamotrigine, the active ingredient in Lamotrigina Viatris, is an anticonvulsant presented as an oral formulation for oral use. It treats partial and generalized seizures in epilepsy and serves as a mood stabilizer for bipolar disorder. It is indicated for patients requiring long‑term seizure control and mood stabilization, and is administered under medical supervision.

GNH USA supplies Lamotrigina Viatris as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to strict quality standards and provides regulatory documentation to facilitate import and distribution across European and global markets.

Lamotrigine is used to manage seizure disorders and mood instability.

- Partial seizures: reduces frequency of focal onset seizures in epilepsy patients. - Generalized seizures: helps control tonic‑clonic and absence seizures across the epileptic spectrum. - Bipolar disorder: stabilizes mood and decreases the risk of depressive and manic episodes.

Lamotrigine may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Dizziness - Headache - Nausea - Rash - Blurred vision - Insomnia

Serious or Rare Side Effects: - Stevens‑Johnson syndrome or toxic epidermal necrolysis - Aseptic meningitis - Blood dyscrasias such as agranulocytosis - Severe hepatic injury - Life‑threatening hypersensitivity reactions

When prescribing lamotrigine, clinicians should consider several safety precautions.

- Pregnancy: risk to fetus is unknown; evaluate benefits versus risks with a healthcare provider. - Breastfeeding: lamotrigine is excreted in milk; caution advised. - Renal impairment: dose may need adjustment in patients with reduced kidney function. - Concomitant valproic acid: may increase lamotrigine plasma levels, requiring dose reduction. - Abrupt discontinuation: can precipitate seizure worsening; taper gradually under medical supervision. - Store at ambient temperature: keep below 25 °C in original packaging, protect from moisture.

Lamotrigine interacts with several medications that can alter its plasma concentration or increase toxicity.

Major Interactions (Avoid): - Valproic acid: markedly raises lamotrigine levels; avoid co‑administration or reduce dose. - Carbamazepine: lowers lamotrigine concentrations, reducing efficacy. - Phenobarbital: induces metabolism, decreasing lamotrigine exposure.

Moderate Interactions (Monitor Closely): - Oral contraceptives: increase lamotrigine clearance, may require dose adjustment. - Serotonergic agents (e.g., SSRIs, SNRIs): potential for serotonin syndrome. - Other antiepileptic drugs: may necessitate therapeutic monitoring.